Every figure this model derived for ECG, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.
This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.
| Figure | Value | XBRL tag | As at |
|---|---|---|---|
| capex | 70,813,000 | PaymentsToAcquireProductiveAssets |
2026-06-30 |
| cash | 176,670,000 | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
2026-06-30 |
| current assets | 1,476,607,000 | AssetsCurrent |
2026-06-30 |
| current liabilities | 930,226,000 | LiabilitiesCurrent |
2026-06-30 |
| equity | 773,201,000 | StockholdersEquity |
2026-06-30 |
| interest expense | 19,702,000 | InterestExpenseNonoperating |
2026-06-30 |
| ocf | 321,185,000 | NetCashProvidedByUsedInOperatingActivities |
2026-06-30 |
| revenue | 4,266,792,000 | RevenueFromContractWithCustomerExcludingAssessedTax |
2026-06-30 |
| sbc | 8,697,000 | ShareBasedCompensation |
2026-06-30 |
The figures themselves rather than their scores — what somebody looking up ECG on one particular measure came for.
| Ratio | Value |
|---|---|
| cash operating margin | 8.7 |
| current ratio | 2.89 |
| current ratio reported | 1.59 |
| deferred revenue growth | 81.82 |
| dilution pct | 0.1 |
| ebit cagr | 22.08 |
| ebit yoy | 48.17 |
| fcf margin | 5.87 |
| growth cv | 1.11 |
| interest cover | 16.79 |
| net debt ebitda | 0.31 |
| operating margin | 7.75 |
| owner earnings margin | 5.66 |
| revenue growth | 30.53 |
| revenue growth per share | 30.4 |
| roic | 29.49 |
| rpo growth | 47.39 |
| rule of 40 | 38.28 |
| sbc pct revenue | 0.2 |
What this model itself distrusts about ECG's figures. Written by the derivation as it ran, not added afterwards.